458 related articles for article (PubMed ID: 22710176)
1. Regulation of EMT by TGFβ in cancer.
Heldin CH; Vanlandewijck M; Moustakas A
FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
[TBL] [Abstract][Full Text] [Related]
2. Induction of epithelial-mesenchymal transition by transforming growth factor β.
Moustakas A; Heldin CH
Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
4. LIM-domain proteins in transforming growth factor β-induced epithelial-to-mesenchymal transition and myofibroblast differentiation.
Järvinen PM; Laiho M
Cell Signal; 2012 Apr; 24(4):819-25. PubMed ID: 22182513
[TBL] [Abstract][Full Text] [Related]
5. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
6. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
Yoshida GJ; Saya H
Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis.
Nawshad A; Lagamba D; Polad A; Hay ED
Cells Tissues Organs; 2005; 179(1-2):11-23. PubMed ID: 15942189
[TBL] [Abstract][Full Text] [Related]
8. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
[TBL] [Abstract][Full Text] [Related]
9. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
10. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation.
de Iongh RU; Wederell E; Lovicu FJ; McAvoy JW
Cells Tissues Organs; 2005; 179(1-2):43-55. PubMed ID: 15942192
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
13. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
[TBL] [Abstract][Full Text] [Related]
14. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.
Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R
Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216
[TBL] [Abstract][Full Text] [Related]
16. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
17. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
Räsänen K; Vaheri A
J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
[TBL] [Abstract][Full Text] [Related]
20. EMT as the ultimate survival mechanism of cancer cells.
Tiwari N; Gheldof A; Tatari M; Christofori G
Semin Cancer Biol; 2012 Jun; 22(3):194-207. PubMed ID: 22406545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]